Medical Net, Inc. (TYO:3645)
Japan · Delayed Price · Currency is JPY 230.00
-2.00 (-0.86%)
Nov 2, 2026, 3:30 PM JST
Medical Net Financials Overview
Financials in millions JPY. Fiscal year is June - May.
Millions JPY. Fiscal year is Jun - May.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Revenue Revenue Growth | 6,725 | 6,732 | 6,077 | 5,252 | 4,500 | 3,745 |
Revenue Growth | 7.09% | 10.78% | 15.71% | 16.71% | 20.16% | 12.46% |
Gross Profit Gross Profit Growth | 1,919 | 1,996 | 1,965 | 1,841 | 1,780 | 1,460 |
Operating Income Operating Income Growth | 145 | 192 | 99 | 299 | 379 | 450 |
Net Income Net Income Growth | 74 | 137 | -68 | 5 | 116 | 384 |
Earnings Per Share EPS Growth | 8.01 | 14.91 | -7.62 | 0.55 | 12.95 | 43.88 |
EPS Growth | - | - | - | -95.73% | -70.50% | 187.19% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Intersegment Transaction Elimination Intersegment Transaction Elimination Growth | -1.04 | -3.46 | -0.33 | -0.11 | -0.24 | -0.91 |
Medical Institution Administration Support Business Medical Institution Administration Support Business Growth | 5,219 | 5,199 | 4,419 | 3,865 | 3,255 | 2,580 |
Medical B to B Business Medical B to B Business Growth | 219.49 | 181.84 | 158.33 | 184.78 | 181.59 | 168.93 |
Media Platform Business (Including Portal Site Management Business) Media Platform Business (Including Portal Site Management Business) Growth | 926.7 | 974.61 | 1,083 | 1,125 | 1,061 | 994.25 |
Cloud Integration Business Cloud Integration Business Growth | 361.31 | 379.36 | 375.08 | 47.54 | - | - |
Others Others Growth | 0.47 | 0.29 | 1 | 29.42 | 3.62 | 3.63 |
Preventive and Disease Prevention Platform Business Preventive and Disease Prevention Platform Business Growth | - | - | 41.01 | - | - | - |
Total Total Growth | 6,726 | 6,732 | 6,078 | 5,252 | 4,501 | 3,746 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Cash & Investments Cash & Investments Growth | 1,969 | 1,956 | 1,456 | 1,528 | 1,518 | 1,133 |
Total Debt Total Debt Growth | 1,403 | 1,421 | 1,251 | 1,029 | 789 | 773 |
Net Cash (Debt) Net Cash Growth | 566 | 535 | 205 | 499 | 729 | 360 |
Net Cash Growth | 74.69% | 160.98% | -58.92% | -31.55% | 102.50% | -25.93% |
Net Cash Per Share Net Cash Per Share Growth | 61.25 | 58.22 | 22.97 | 55.17 | 81.35 | 41.14 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 98 | -80 | 119 | 429 | 342 |
Capital Expenditures CapEx Growth | - | -8 | -131 | -32 | -19 | -2 |
Free Cash Flow Free Cash Flow Growth | - | 90 | -211 | 87 | 410 | 340 |
Free Cash Flow Growth | - | - | - | -78.78% | 20.59% | -10.05% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Gross Margin | 28.54% | 29.65% | 32.34% | 35.05% | 39.56% | 38.98% |
Operating Margin | 2.16% | 2.85% | 1.63% | 5.69% | 8.42% | 12.02% |
Pretax Margin | 2.56% | 3.83% | 0.39% | 2.88% | 5.56% | 14.31% |
Profit Margin | 1.10% | 2.04% | -1.12% | 0.10% | 2.58% | 10.25% |
FCF Margin | - | 1.34% | -3.47% | 1.66% | 9.11% | 9.08% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 2, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 3.000 | 3.000 | 3.000 | 3.000 | 2.500 | 2.500 |
Dividend Per Share Growth | 0% | 0% | 0% | 20.00% | 0% | 0% |
Dividend Yield | 1.30% | 1.13% | 0.92% | 0.81% | 0.64% | 0.54% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 2, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
PE Ratio | 28.72 | 17.89 | - | 665.73 | 30.65 | 10.70 |
P/FCF Ratio | 23.45 | 27.23 | - | 38.26 | 8.67 | 12.08 |
PS Ratio | 0.31 | 0.36 | 0.47 | 0.63 | 0.79 | 1.10 |